These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8333180)

  • 1. [Features of lipid peroxidation in the blood of patients with chronic glomerulonephritis at the stage of renal dysfunction in the presence of nephrotic syndrome].
    Tugusheva FA; Kulikova AI; Zubina IM
    Vopr Med Khim; 1993; 39(3):18-21. PubMed ID: 8333180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI; Kulikova AI; Tugusheva FA; Zubina IM; Kozlov VV
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome].
    Shishkin AN; Kolmakova EV; Ashirova KV
    Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Variants in the transient deterioration of kidney function in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1996; 68(11):62-7. PubMed ID: 9045385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of pathogenetic therapy on the expression of endogenous intoxication in patients with chronic glomerulonephritis].
    Rumiantsev ISh; Kaznacheeva IG; Abdiadilova LV; Kozlov VV
    Ter Arkh; 1992; 64(6):35-9. PubMed ID: 1440334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The blood pro- and antioxidant status in patients with chronic glomerulonephritis and disordered kidney function undergoing treatment with peroral sorbents].
    Tugusheva FA; Kulikova AI; Lukichev BG; Zubina IM
    Urol Nefrol (Mosk); 1994; (6):39-42. PubMed ID: 7892720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelogenous leukemia with nephrotic syndrome.
    Sudholt BA; Heironimus JD
    Arch Intern Med; 1983 Jan; 143(1):168-9. PubMed ID: 6571779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy in teaching hospitals of Dhaka.
    Sharmin F; Khan BR; Rahman M; Rashid HU; Islam B; Kamal M; Barua AR; Chowdhury MA; Mohsin AU; Ahmed S
    Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):25-9. PubMed ID: 9363674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pentoxifylline (Trental) in the treatment of chronic glomerulonephritis].
    Shoĭkhet IN; Treĭvish VS; Novikova NN
    Ter Arkh; 1986; 58(8):71-3. PubMed ID: 3764765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrotic syndrome in chronic glomerulonephritis and tonsillectomy].
    Radecki A
    Wiad Lek; 1971 Dec; 24(23):2165-71. PubMed ID: 5160970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical assessment of lipid free-radical oxidation in chronic glomerulonephritis patients].
    Nazar PS; Galitskiĭ IaD; Martyniuk ES
    Ter Arkh; 1987; 59(9):104-6. PubMed ID: 3424171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
    Duman VL
    Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranous glomerulonephritis with nephrotic syndrome in transplanted kidney.
    Kulig A; Markiewicz K; Moll J; Rybiński K; Szram S; Trznadel K; Wisniewski J
    Acta Med Pol; 1971; 12(1):55-64. PubMed ID: 4925634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basal metabolism in patients with chronic glomerulonephritis and isolated urinary syndrome].
    Todorenko AD
    Vrach Delo; 1975 Jul; (7):39-41. PubMed ID: 1220225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antithrombotic therapy in correcting hemostatic disorders in patients with chronic glomerulonephritis].
    Nazar PS; Badiuk RA
    Vrach Delo; 1990 Mar; (3):18-20. PubMed ID: 2368351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membranous nephropathy and crescentic glomerulonephritis].
    Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F
    Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrotic syndrome (clinico-morphological, immunological and biochemical aspects)].
    Riabov SI; Kozlov VV; Kozhevnikov AD; Rakitianskaia IA; Smirnov AV
    Ter Arkh; 1988; 60(6):24-8. PubMed ID: 3206362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.